Published • loading... • Updated
Altis Labs Raises US$25 Million Series A Co-Led by OrbiMed and Qiming Venture Partners USA to Accelerate Clinical Development with AI Endpoints
Summary by Financial Post
3 Articles
3 Articles
Financial Post+2 Reposted by 2 other sources
Altis Labs Raises US$25 Million Series A Co-Led by OrbiMed and Qiming Venture Partners USA to Accelerate Clinical Development with AI Endpoints
TORONTO — Altis Labs, Inc. (“Altis”), the AI endpoint company, today announced the closing of its US$25 million Series A financing. The round was co-led by OrbiMed…
·Toronto, Canada
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
